Projects per year
Fingerprint
Dive into the research topics where Matthias D'Huyvetter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IOF3036: INTEGRAL - Integrating a multimodal approach to address current challenges in immunotherapy
Van Ginderachter, J. (Administrative Promotor), Laoui, D. (CoI (Co-Promotor)), Movahedi, K. (CoI (Co-Promotor)), Hadadi, E. (CoI (Co-Promotor)), Stijlemans, B. (CoI (Co-Promotor)), Raes, G. (CoI (Co-Promotor)), Devoogdt, N. (CoI (Co-Promotor)), Lahoutte, T. (CoI (Co-Promotor)), De Groof, T. (CoI (Co-Promotor)), Goyvaerts, C. (CoI (Co-Promotor)), D'Huyvetter, M. (CoI (Co-Promotor)), Debacker, J. (CoI (Co-Promotor)), Breckpot, K. (CoI (Co-Promotor)), Franceschini, L. (CoI (Co-Promotor)), Raes, G. (Mandate) & Revets, H. (Mandate)
1/01/25 → 31/12/29
Project: Applied
-
FWOIRI10: Research on radioactive nuclei at ISOLDE-CERN, SPIRAL2- GANIL and MEDICIS-CERN
Caveliers, V. (Administrative Promotor) & D'Huyvetter, M. (Co-Promotor)
1/01/23 → 31/12/26
Project: Fundamental
-
HERC59: CASA PETIt: CAmera for Small Animal PET-Imaging
Devoogdt, N. (Administrative Promotor), Raes, G. (Co-Promotor), Lahoutte, T. (Co-Promotor), Van Ginderachter, J. (Co-Promotor), Caveliers, V. (Co-Promotor), Keyaerts, M. (Co-Promotor), Hernot, S. (Co-Promotor) & D'Huyvetter, M. (Co-Promotor)
1/05/22 → 30/04/26
Project: Fundamental
-
FWOSB116: Evaluation of an in vivo pre-targeting approach for targeted radionuclide therapy of cancer using clickable anti-B7-H3 single domain antibodies.
Funeh, C. N. (Mandate), Devoogdt, N. (Administrative Promotor) & D'Huyvetter, M. (Scientific Promotor)
1/11/21 → 31/10/25
Project: Fundamental
-
FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Breckpot, K. (Administrative Promotor), Devoogdt, N. (Co-Promotor), D'Huyvetter, M. (Co-Promotor), Keyaerts, M. (Co-Promotor) & Ertveldt, T. (Mandate)
1/11/19 → 31/10/23
Project: Fundamental
-
Design and Preclinical Validation of an Anti-B7-H3-Specific Radiotracer: A Non-Invasive Imaging Tool to Guide B7-H3-Targeted Therapies
Funeh, C. N., Meeus, F., De Groof, T., D'Huyvetter, M. & Devoogdt, N., 30 Sept 2025, In: Pharmaceuticals. 18, 10, 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Ceuppens, H., Pombo Antunes, A. R., Navarro, L., Ertveldt, T., Berdal, M., Nagachinta, S., De Ridder, K., Lahoutte, T., Keyaerts, M., Devoogdt, N., Goyvaerts, C., D'Huyvetter, M. & Breckpot, K., Jan 2025, In: European Journal of Nuclear Medicine and Molecular Imaging. 52, 2, p. 444-457 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)8 Downloads (Pure) -
Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model
Ceuppens, H., De Ridder, K., Ertveldt, T., Zeven, K., de Mey, W., Pombo Antunes, A. R., Navarro, L., Dumauthioz, N., Lahoutte, T., Debacker, J., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Goyvaerts, C. & Breckpot, K., 1 Dec 2025, In: Oncoimmunology. 14, 1, 16 p., 2540054.Research output: Contribution to journal › Article › peer-review
Open Access -
Novel Resin-Based Recovery of Astatine-211 : A Breakthrough for Efficient Radiolabeling
Navarro, L., Sevenois, M., Ertveldt, T., Zeven, K., Jensen, H. J., Haddad, F., D'Huyvetter, M. & Covens, P., 12 May 2025. 1 p.Research output: Unpublished contribution to conference › Poster
File4 Downloads (Pure) -
Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
Dewulf, J., Massa, S., Navarro, L., Dekempeneer, Y., Santens, F., Ceuppens, H., Breckpot, K., Van Ginderachter, J. A., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 19 Dec 2024, In: Journal of Nanobiotechnology. 22, 1, 13 p., 763.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Citations (Scopus)4 Downloads (Pure)
Datasets
-
DataSet-Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model
Ertveldt, T. (Creator), De Beck, L. (Creator), De Ridder, K. (Creator), Locy, H. (Creator), de Mey, W. (Creator), Goyvaerts, C. (Creator), Lecocq, Q. (Creator), Ceuppens, H. (Creator), De Vlaeminck, Y. (Creator), Awad, R. M. (Creator), Keyaerts, M. (Creator), Devoogdt, N. (Creator), D'Huyvetter, M. (Creator), Breckpot, K. (Creator) & Krasniqi, A. (Creator), Zenodo, 16 Dec 2024
Dataset
Prizes
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Krasniqi, A. (Recipient), D'Huyvetter, M. (Recipient), Devoogdt, N. (Recipient) & Keyaerts, M. (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
-
Award of the Fonds Germaine Eisendrath Dubois (FGED)
D'Huyvetter, M. (Recipient), 2012
Prize: Prize (including medals and awards)
-
-
-
Travel Award of Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO)
D'Huyvetter, M. (Recipient), 7 Sept 2016
Prize: Prize (including medals and awards)
Activities
-
Astatine-211: 'The rarest material on earth is more accessible than you think'.
Sevenois, M. (Speaker), Navarro, L. (Contributor), D'Huyvetter, M. (Contributor) & Covens, P. (Contributor)
26 Apr 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.
Ceuppens, H. (Speaker), Pombo Antunes, A. R. (Contributor), Navarro, L. (Contributor), Ertveldt, T. (Contributor), Berdal, M. (Contributor), Nagachinta, S. (Contributor), De Ridder, K. (Contributor), Keyaerts, M. (Contributor), Devoogdt, N. (Contributor), Goyvaerts, C. (Contributor), D'Huyvetter, M. (Contributor) & Breckpot, K. (Contributor)
23 Oct 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Optimization production yield of 211At
Sevenois, M. (Invited speaker), D'Huyvetter, M. (Contributor), Haddad, F. (Contributor) & Covens, P. (Contributor)
10 May 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
SCK NMA-talk
Ertveldt, T. (Presenter), Devoogdt, N. (Invited speaker) & D'Huyvetter, M. (Contributor)
14 Nov 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Optimizing the yield of 211At
Sevenois, M. (Invited speaker), Jensen, H. (Contributor), D'Huyvetter, M. (Contributor) & Covens, P. (Contributor)
10 May 2022Activity: Talk or presentation › Talk or presentation at a workshop/seminar
Press/Media
-
Brussels, City of Innovators - Matthias D'Huyvetter
28/01/21
1 Media contribution
Press/Media: Research
-
Camel blood to fight cancer? This VUB spin-off is getting amazing results
Lahoutte, T., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
17/11/17
1 Media contribution
Press/Media: Research
-
Kanker bestrijden met elektrische fietsjes in het bloed
Lahoutte, T., Devenyns, R., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
17/10/17
1 Media contribution
Press/Media: Research
-
Lama-antistoffen in strijd tegen kanker
Lahoutte, T., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
30/03/17
1 Media contribution
Press/Media: Research
-
Wat is borstkanker en hoe wordt deze ziekte behandeld?
27/02/17
1 Media contribution
Press/Media: Research
Thesis
-
CD20 Nb TRNT: targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Devoogdt, N. (Promotor), D'Huyvetter, M. (Promotor) & Tavernier, J. (Co-promotor), 24 May 2019Student thesis: Doctoral Thesis
-
Characterization of anti-B7-H3 single domain antibody fragments for imaging and targeted radionuclide therapy of cancer
Munir, A. ((PhD) Student), D'Huyvetter, M. (Promotor) & Devoogdt, N. (Co-promotor), Funeh, C. N. (Advisor), 4 Sept 2023Student thesis: Master's Thesis
-
Development and characterization of a novel pan-cancer radiotheranostic agent
Laaniber, M. ((PhD) Student), D'Huyvetter, M. (Promotor) & Devoogdt, N. (Co-promotor), 17 Jun 2022Student thesis: Master's Thesis
-
EGFRvIII Nb TRNT: Evaluation of radiolabeled nanobodies for the treatment of cancers expressing mutant EGFR’
Puttemans, J. ((PhD) Student), Devoogdt, N. (Promotor), D'Huyvetter, M. (Promotor) & Muyldermans, S. (Co-promotor), 4 Mar 2021Student thesis: Doctoral Thesis
-
Evaluation of anti-idiotype Nanobodies in a preclinical model of Multiple Myeloma
Sharma, P. ((PhD) Student), Puttemans, J. (Advisor), Devoogdt, N. (Promotor), D'Huyvetter, M. (Co-promotor) & Muyldermans, S. (Co-promotor), 2019Student thesis: Master's Thesis